Home › Funds › WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC › MDGL

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reported holding 337,035 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$169.9M, representing 0.55% of its reported portfolio and ranking #41 among its reported holdings. WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed MDGL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)337.04K sh
Reported value held$169.85M
Portfolio Weight0.55%
First reportedQ4 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's MDGL position evolved

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC first disclosed a stake in MDGL in Q4 2024 at 371,771 shares (US$114.7M). The position peaked in Q4 2025 at 354,220 shares, worth US$206.3M. Across 8 filings, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 337,035 shares valued at US$169.9M — an increase of 12,912 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 371.77K $114.72M New
Q1 2025 353.15K $116.98M Reduce
Q2 2025 350.29K $106.01M Reduce
Q3 2025 411.80K $188.88M Add
Q4 2025 354.22K $206.28M Reduce
Q1 2026 340.52K $178.25M Reduce
Q2 2026 324.12K $174.04M Reduce
Q3 2026 337.04K $169.85M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC held MDGL?

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed MDGL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's current position in MDGL?

As of Q3 2026, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC holds 337.04K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $169.85M, representing 0.55% of its reported portfolio and ranking #41.

Has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC been buying or selling MDGL?

In the latest 13F filing (Q3 2026), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased its position in MDGL. The position peaked in Q4 2025 at 354.22K shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.